• Fri, November 11, 2022
Michael Schmidt Maintained (ZNTL) at Strong Buy with Decreased Target to $28 on, Nov 11th, 2022
Michael Schmidt of Guggenheim, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Decreased Target from $55 to $28 on, Nov 11th, 2022.
Michael has made no other calls on ZNTL in the last 4 months.
There are 5 other peers that have a rating on ZNTL. Out of the 5 peers that are also analyzing ZNTL, 0 agree with Michael's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Michael
- Andrew Berens of "SVB Leerink" Maintained at Buy with Decreased Target to $27 on, Thursday, November 10th, 2022
- Matthew Biegler of "Oppenheimer" Maintained at Buy with Decreased Target to $50 on, Thursday, November 10th, 2022
- Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $58 on, Wednesday, November 9th, 2022
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $55 on, Wednesday, August 10th, 2022
- Tyler Van Buren of "Cowen & Co." Initiated at Buy on, Tuesday, July 12th, 2022
Like: 👍
